Industry: Healthcare | Publish Date: 27-Nov-2024 | No of Pages: 400 | No. of Tables: 197 | No. of Figures: 173 | Format: PDF | Report Code : HC19
The global Bone Grafts and Substitutes Market size valued USD 2.96 billion in 2019, and is predicted to reach USD 4.85 billion by 2030, witnessing a CAGR of 4.5% from 2020-2030. Bone grafting is a surgical procedure to operate extremely complicated bone fractures whereas bone grafts are implantable materials, used during the procedure to promote bone healing, bone formation, and osseous reconstruction.
Depending on the grafting procedure, the bone grafts may be autologous, allograft or synthetic with mechanical properties replicating the bone. These grafts soon get reabsorbed and replaced with the healing of natural bone, and their efficacy depend on three basic principles viz. osteoconduction, osteoinduction, and osteogenesis. Bone grafts hold wide applications in spinal fusion, trauma, dental bone grafting, craniomaxillofacial, joint reconstruction and other bone grafting procedures.
According to World Population Ageing data provided by the United Nations, the global population aged 60 years or above numbered 962 million in 2017, and is expected to reach 2.1 billion by 2050. According to the report published by Centres for Disease Control and Prevention, in 2017, 60% of the elderly population was affected by spinal deformities. This prevailing condition gives rise to an increase in demand for bone grafts and substitutes in the grafting procedures, hence propagating the growth of the bone grafts and substitutes market.
The global bone grafts and substitutes market has observed substantial growth in the past few years, and is expected to witness gigantic opportunities, in the coming future. The factors fostering the market growth are, increasing rate of spinal deformities, multiplying number of road accidents and sports injuries, growing incidences of joint disorders, hip fractures, osteoporosis and arthritis, especially in women. Growing demand for dental bone grafts, higher adoption of minimally invasive surgeries, lucrative benefits offered by health-care insurance and Mediclaim agencies.
However, high cost of bone grafting surgeries, as well as risk and complications associated with grafting procedures, are the factors responsible in hampering the bone grafts and substitutes market growth during the forecast period. Moreover, factors such as increase in per-capita disposable income, advancements in healthcare infrastructures, growing penetration of orthopedic specialty hospitals, increasing government initiatives offering low-cost medical services and subsidiaries, as well as upsurge in R&D activities regarding biocompatible synthetic bone grafts, are anticipated in providing avenues for the growth of bone grafts and substitutes market in the coming future.
The bone grafts and substitutes market share analysis is based on type, application, material type, and geography. Based on type, the market is segmented into bone graft substitutes, allograft, and cell-based matrices. Based on application, the market covers spinal fusion, trauma, dental bone grafting, craniomaxillofacial, and joint reconstruction.
Based on the type of material, the bone grafts and substitutes market is divided into collagen, hydroxyapatite, tricalcium phosphate, human cell source, animal source, and others. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
North America region is expected to dominate the global bone grafts and substitutes industry throughout the forecast period, accounting for the highest market shares. This is attributed to factors such as well-established orthopedic specialty healthcare infrastructures, better reimbursement facilities, higher adoption of advanced medical technologies, higher investments in R&D activities, and presence of key players in this region.
It is expected that the emerging economies, specifically in the Asia-Pacific region shall witness increasing size of the bone grafts and substitutes market, owing to rapidly increasing geriatric population, growing adoption of bone grafts and substitutes in grafting modalities, as well as presence of large patient pool migrates in this region.
Comprehensive competitive analysis and profiles of the major market players such as Johnson & Johnson, Arthrex, Inc., Baxter International Inc., Zimmer Biomet Holdings, Integra LifeSciences Holdings Corporation, Wright Medical Group N.V., Stryker Corporation, Musculoskeletal Transplant Foundation, NuVasive, Inc., Medtronic Plc., Inc., and others are provided in the bone grafts and substitutes market report.
An upsurge in R&D activities and advancement in product technology with new product launches by the key players, is leading the healthcare infrastructure to new heights, by creating lucrative opportunities for the global bone grafts and substitutes market.
For instance, in January 2020, Medtronic Plc., a global leader in medical technology, chose Barrow Neurological Institute (BNI) at the Phoenix Children’s Hospital, a Nationally ranked pediatric leader in the US, as its first partner for application of its ‘Medtronic Stealth Autoguide: the Cranial Robotic Guidance Platform for Neurosurgery.’ This robotic technology is FDA approved and its highly advanced surgical tools are intended for use with the Medtronic Stealth Station system. The Phoenix Children’s Hospital aims at using this robotic technology in surgery for pediatric patients suffering from a range of neurological conditions, hence being at the forefront of surgical innovations and having the most advanced solutions for pediatric patients.
The bone grafts and substitutes market report provide a quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.
The study comprises a deep dive analysis of the bone grafts and substitutes industry, including current and future market trends for depicting the prevalent investment pockets in the market.
The report provides detailed information related to key drivers, restraints, opportunities and their impact on the global market.
The report incorporates competitive analysis of the market players along with their market size and share in the global market for bone grafts and substitutes.
The study elaborates on the SWOT analysis and Porter's Five Forces model along with bone grafts and substitutes market trend analysis.
Value chain analysis in the bone grafts and substitutes market study provides a clear picture of the stakeholders’ roles.
Bone Graft Substitutes
Allograft
Cell-based Matrices
Spinal Fusion
Trauma
Dental Bone Grafting
Craniomaxillofacial
Joint Reconstruction
Collagen
Human Cell Source
Animal Source
Hydroxyapatite
Tricalcium Phosphate
Others
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
RoW
UAE
Saudi Arabia
South Africa
Brazil
Rest of RoW
Baxter International Inc.
Integra LifeSciences Holdings Corporation
Arthrex, Inc.
Johnson & Johnson
Wright Medical Group N.V.
Medtronic Plc.
Zimmer Biomet Holdings, Inc.
Stryker Corporation
Musculoskeletal Transplant Foundation
NuVasive, Inc.
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Analysis Period |
2019–2030 |
Base Year Considered |
2019 |
Forecast Period |
2020–2030 |
Market Size Estimation |
Billion (USD) |
Market Segmentation |
By Type (Bone Graft Substitutes, Allograft, Cell-based Matrices), Material Type (Collagen, Human Cell Source, Animal Source, Hydroxyapatite, Tricalcium Phosphate, Others), Application (Spinal Fusion, Trauma, Dental Bone Grafting, Craniomaxillofacial, Joint Reconstruction) |
Geographical Segmentation |
North America (US, Canada, Mexico) Europe (Germany, UK, France, Italy, Rest of Europe) APAC (China, Japan, India, Australia, Rest of APAC) Rest of World (UAE, Saudi Arabia, South Africa, Brazil, Rest of RoW) |
Companies Profiled |
Johnson & Johnson, Arthrex, Inc., Baxter International Inc., Zimmer Biomet Holdings, Integra LifeSciences Holdings Corporation, Wright Medical Group N.V., Stryker Corporation, Musculoskeletal Transplant Foundation, NuVasive, Inc., Medtronic Plc., Inc. |